CDI LABORATORIES, INC
MAYAGUEZ, PR · CIK 0001646316 · Medtech · Private
Intraoperative Neurophysiological Monitoring (IOM) services and systems for real-time nerve function assessment during surgery
cdi.com →- Grants
- $898K
- 4 awards
- Sector median: 1
- Raised
- $3.3M
- 2 Form D · Jan 2021
- 69 months since last filing
- Contracts
- $112K
- 6 awards · Health and Human S
- #511 of 4531 in medtech
- Patents
- 17
- 0 granted · 17 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20122014201620182020
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Health and Human Services · Igf::ot::igf Professional Services / Cdi Laboratories / Sasser | $20,250 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf Cdi Laboratories INC:1188045 [13-009563] | $23,750 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf Cdi Laboratories INC:1188045 [13-010562] | $14,750 | |
| Federal contract | Department of Health and Human Services · Cdi Laboratories INC:1188045 [13-010550] | $24,000 | |
| Federal contract | Department of Health and Human Services · Igf::ct::igfcdi Laboratories INC:1188045 [13-016572] | $5,455 | |
| Federal contract | Department of Health and Human Services · Cdi Laboratories INC:1188045 [14-001004] | $24,000 | |
| Private capital raised | Form D · SEC | $1,191,901 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Monospecific monoclonal antibodies against human protein complexes on an interactome-wide scale. | $294,320 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Monospecific monoclonal antibodies against human protein complexes on an interactome-wide scale. | $294,320 | |
| Federal grant | Department of Health and Human Services · Phase I · Validation of immune-based biomarkers for endometriosis. | $154,596 | |
| Federal grant | Department of Health and Human Services · Phase I · Validation of immune-based biomarkers for endometriosis. | $154,596 | |
| Private capital raised | Form D · SEC | $2,099,790 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 508 | SANUWAVE Health, Inc. | $117K | $81M |
| 509 | PURIGEN BIOSYSTEMS, INC. | $116K | $48M |
| 510 | Egg Medical, Inc. | $115K | $28M |
| 511 | CDI LABORATORIES, INC | $112K | $3.3M |
| 512 | NCAP MEDICAL, LLC | $111K | — |
| 513 | GREAT LAKES NEUROTECHNOLOGIES INC. | $109K | — |
| 514 | ALM Ortho Inc | $107K | $135K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Jef BoekeDirector
- Joseph BonaventuraDirector
- Antoine de MarsilyDirector
- Daniel EichingerDirector
- Paul HoranDirector
- Ignacio Pino Lopez-CastroDirector · Executive Officer
Patents
- Mapping Dna Bindingapplication
- Serological Biomarkers For Early Diagnosis Of Lung Cancerapplication
- Pan-Isotype Immunoglobulin Fingerprintingapplication
- Pan-isotype Immunoglobulin Fingerprintingapplication
- Compositions And Methods For Analyzing Nucleic Acids Associated With An Analyteapplication
- Methods And Compositions To Identify, Quantify, And Characterize Target Analytes And Binding Moietiesapplication
- Methods And Compositions To Identify, Quantify, And Characterize Target Analytes And Binding Moietiesapplication
- Methods And Compositions To Identify, Quantify, And Characterize Target Analytes And Binding Moietiesapplication
- Methods And Compositions To Identify, Quantify, And Characterize Target Analytes And Binding Moietiesapplication
- Methods And Compositions To Identify, Quantify, And Characterize Target Analytes And Binding Moietiesapplication
- Methods And Compositions To Identify, Quantify, And Characterize Target Analytes And Binding Moietiesapplication
- Mapping Dna Bindingapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.